Centene Corporation is a large publicly traded company and a multi-line managed care enterprise that serves as a major intermediary for both government-sponsored and privately insured health care programs. It is a healthcare insurer that focuses on managed care for uninsured, underinsured, and low-income individuals.
| Revenue (TTM) | $180.41B |
| Gross Profit (TTM) | $20.46B |
| EBITDA | $4.69B |
| Operating Margin | 0.74% |
| Return on Equity | 6.74% |
| Return on Assets | 2.68% |
| Revenue/Share (TTM) | $366.02 |
| Book Value | $44.87 |
| Price-to-Book | 1.65 |
| Price-to-Sales (TTM) | 0.19 |
| EV/Revenue | 0.141 |
| EV/EBITDA | 7.58 |
| Quarterly Earnings Growth (YoY) | 18.30% |
| Quarterly Revenue Growth (YoY) | 0.20% |
| Shares Outstanding | $495.07M |
| Float | $464.75M |
| % Insiders | 0.39% |
| % Institutions | 101.50% |
Volatility is currently expanding
HCA posted its biggest one-day jump in four years before a single law changed. Wall Street is pricing in relief that needs Congress, a presidential signature, and a December funding fight to survive.
Midterm election results are reshaping sector sentiment, putting Nextpower, Centene & AI infrastructure companies in focus amid shifting policy expectations.
Centene (CNC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Discover four GARP stocks, APA, T-Mobile, BP and Centene, that combine attractive valuations with sustainable earnings growth potential amid market volatility.
CNC raises its 2026 earnings outlook after Q3 results beat estimates, as Medicare recovery accelerates despite Medicaid enrollment and margin risks.
Does Centene (CNC) have what it takes to be a top stock pick for momentum investors? Let's find out.
Centene NYSE: CNC raised its full-year 2026 adjusted earnings outlook after reporting third-quarter results that exceeded its prior expectations, supported by stronger Medicare performance and in-line execution in Medicaid and commercial insurance.
Centene Corporation (CNC) Q3 2026 Earnings Call Transcript
Centene's Q3 earnings beat estimates as Medicare revenues surge 19.9% despite falling membership, while management lifts its 2026 adjusted profit outlook.
Although the revenue and EPS for Centene (CNC) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on CNC and any ticker you trade — then tracks every position and per-strategy win rate.
